(Q73911971)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9385122%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

title

Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9385122%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Effects of Raloxifene on Bone Mineral Density, Serum Cholesterol Concentrations, and Uterine Endometrium in Postmenopausal Women (English)

1 reference

https://api.crossref.org/works/10.1056/NEJM199712043372301

26 November 2024

author name string

P. D. Delmas

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9385122

26 November 2024

N. H. Bjarnason

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9385122

26 November 2024

B. H. Mitlak

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9385122

26 November 2024

A. C. Ravoux

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9385122

26 November 2024

A. S. Shah

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9385122

26 November 2024

W. J. Huster

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9385122

26 November 2024

M. Draper

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9385122

26 November 2024

C. Christiansen

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9385122

26 November 2024

publication date

1 December 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9385122%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

4 December 1997

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9385122

full work available at URL

26 November 2024

language of work or name

English

0 references

http://www.nejm.org/doi/pdf/10.1056/NEJM199712043372301

1 reference

https://api.crossref.org/works/10.1056/NEJM199712043372301

The New England Journal of Medicine

26 November 2024

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9385122%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

volume

337

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9385122%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

issue

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9385122%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

page(s)

1641-1647

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9385122%20AND%20SRC:MED&resulttype=core&format=json

Hormone replacement therapy and endometrial cancer risk: a meta-analysis

7 November 2019

cites work

1

1 reference

https://api.crossref.org/works/10.1056/NEJM199712043372301

Risk of endometrial cancer in relation to use of oestrogen combined with cyclic progestagen therapy in postmenopausal women

26 November 2024

2

1 reference

https://api.crossref.org/works/10.1056/NEJM199712043372301

The Use of Estrogens and Progestins and the Risk of Breast Cancer in Postmenopausal Women

26 November 2024

3

1 reference

https://api.crossref.org/works/10.1056/NEJM199712043372301

Effects of a new antiestrogen, keoxifene (LY156758), on growth of carcinogen-induced mammary tumors and on LH and prolactin levels

26 November 2024

4

1 reference

https://api.crossref.org/works/10.1056/NEJM199712043372301

Chemoprevention of mammary carcinogenesis in the rat: combined use of raloxifene and 9-cis-retinoic acid

26 November 2024

5

1 reference

https://api.crossref.org/works/10.1056/NEJM199712043372301

Raloxifene (LY139481 HCI) prevents bone loss and reduces serum cholesterol without causing uterine hypertrophy in ovariectomized rats

26 November 2024

6

1 reference

https://api.crossref.org/works/10.1056/NEJM199712043372301

A controlled trial of raloxifene (LY139481) HCl: impact on bone turnover and serum lipid profile in healthy postmenopausal women

26 November 2024

9

1 reference

https://api.crossref.org/works/10.1056/NEJM199712043372301

Identification of an estrogen response element activated by metabolites of 17beta-estradiol and raloxifene

26 November 2024

10

1 reference

https://api.crossref.org/works/10.1056/NEJM199712043372301

Measurement of serum osteocalcin with a human-specific two-site immunoradiometric assay

26 November 2024

11

1 reference

https://api.crossref.org/works/10.1056/NEJM199712043372301

The Jackknife Estimate of Variance

26 November 2024

16

1 reference

https://api.crossref.org/works/10.1056/NEJM199712043372301

Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis

26 November 2024

17

1 reference

https://api.crossref.org/works/10.1056/NEJM199712043372301

Effects of oral alendronate and intranasal salmon calcitonin on bone mass and biochemical markers of bone turnover in postmenopausal women with osteoporosis

26 November 2024

20

1 reference

https://api.crossref.org/works/10.1056/NEJM199712043372301

Four-year study of intermittent cyclic etidronate treatment of postmenopausal osteoporosis: three years of blinded therapy followed by one year of open therapy.

26 November 2024

21

1 reference

https://api.crossref.org/works/10.1056/NEJM199712043372301

The effect of the antiestrogen tamoxifen on bone mineral density in normal late postmenopausal women

26 November 2024

22

1 reference

https://api.crossref.org/works/10.1056/NEJM199712043372301

Effect of tamoxifen on bone mineral density measured by dual-energy x-ray absorptiometry in healthy premenopausal and postmenopausal women

26 November 2024

23

1 reference

https://api.crossref.org/works/10.1056/NEJM199712043372301

Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial

26 November 2024

24

1 reference

https://api.crossref.org/works/10.1056/NEJM199712043372301

Plasma lipoprotein levels as predictors of cardiovascular death in women.

26 November 2024

25

1 reference

https://api.crossref.org/works/10.1056/NEJM199712043372301

Effect of cholesterol-lowering diet on mortality from coronary heart-disease and other causes. A twelve-year clinical trial in men and women.

26 November 2024

27

1 reference

https://api.crossref.org/works/10.1056/NEJM199712043372301

Raloxifene Inhibits Aortic Accumulation of Cholesterol in Ovariectomized, Cholesterol-Fed Rabbits

26 November 2024

28

1 reference

https://api.crossref.org/works/10.1056/NEJM199712043372301

Endometrial changes with tamoxifen: comparison between tamoxifen-treated and nontreated asymptomatic, postmenopausal breast cancer patients

26 November 2024

29

1 reference

https://api.crossref.org/works/10.1056/NEJM199712043372301

Effects of tamoxifen on uterus and ovaries of postmenopausal women in a randomised breast cancer prevention trial

26 November 2024

30

1 reference

https://api.crossref.org/works/10.1056/NEJM199712043372301

26 November 2024

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9385122%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1 reference